These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 30293110)

  • 41. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
    Eftimov F; Winer JB; Vermeulen M; de Haan R; van Schaik IN
    Cochrane Database Syst Rev; 2009 Jan; (1):CD001797. PubMed ID: 19160200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathophysiology of the Different Clinical Phenotypes of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP).
    Dziadkowiak E; Waliszewska-Prosół M; Nowakowska-Kotas M; Budrewicz S; Koszewicz Z; Koszewicz M
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008604
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Quantitative grip force assessment of muscular weakness in chronic inflammatory demyelinating polyneuropathy.
    Klehmet J; Beutner S; Hoffmann S; Dornauer M; Paul F; Reilmann R; Brandt AU; Meisel A
    BMC Neurol; 2019 Jun; 19(1):118. PubMed ID: 31176377
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autologous Hematopoietic Stem Cell Transplantation for Chronic Inflammatory Demyelinating Polyradiculoneuropathy.
    Masson-Roy J; Breiner A; Warman-Chardon J; Pringle CE; Allan D; Bredeson C; Huebsch L; Kekre N; Kennah ML; Martin L; McDiarmid S; Altouri S; Atkins H; Bourque PR
    Can J Neurol Sci; 2021 Nov; 48(6):760-766. PubMed ID: 33631093
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Refractory Chronic Immune-mediated Demyelinating Polyneuropathy.
    Shaibani A; Al Sultani H
    Neurol Clin; 2020 Aug; 38(3):591-605. PubMed ID: 32703471
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic acquired demyelinating symmetric polyneuropathy classified by pattern of weakness.
    Mygland A; Monstad P
    Arch Neurol; 2003 Feb; 60(2):260-4. PubMed ID: 12580713
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of chronic inflammatory demyelinating polyneuropathy with high-dose intermittent intravenous methylprednisolone.
    Lopate G; Pestronk A; Al-Lozi M
    Arch Neurol; 2005 Feb; 62(2):249-54. PubMed ID: 15710853
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Progress in Hematopoietic Stem Cell Transplantation for CIDP.
    Qin Z; Huang Q; Zou J; Tang L; Hu Z; Tang X
    Int J Med Sci; 2020; 17(2):234-241. PubMed ID: 32038107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A pilot study to compare the use of the Excorim staphylococcal protein immunoadsorption system and IVIG in chronic inflammatory demyelinating polyneuropathy.
    Zinman LH; Sutton D; Ng E; Nwe P; Ngo M; Bril V
    Transfus Apher Sci; 2005 Nov; 33(3):317-24. PubMed ID: 16239123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic inflammatory demyelinating polyneuropathy (CIDP): change of serum IgG dimer levels during treatment with intravenous immunoglobulins.
    Ritter C; Bobylev I; Lehmann HC
    J Neuroinflammation; 2015 Aug; 12():148. PubMed ID: 26268846
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chronic inflammatory demyelinating polyradiculoneuropathy in solid organ transplant recipients: a prospective study.
    Echaniz-Laguna A; de Séze J; Chanson JB
    J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):699-705. PubMed ID: 22577230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The gut microbiome in intravenous immunoglobulin-treated chronic inflammatory demyelinating polyneuropathy.
    Svačina MKR; Sprenger-Svačina A; Tsakmaklis A; Rüb AM; Klein I; Wüstenberg H; Fink GR; Lehmann HC; Vehreschild MJGT; Farowski F
    Eur J Neurol; 2023 Nov; 30(11):3551-3556. PubMed ID: 36651357
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Subcutaneous immunoglobulin in responders to intravenous therapy with chronic inflammatory demyelinating polyradiculoneuropathy.
    Markvardsen LH; Debost JC; Harbo T; Sindrup SH; Andersen H; Christiansen I; Otto M; Olsen NK; Lassen LL; Jakobsen J;
    Eur J Neurol; 2013 May; 20(5):836-42. PubMed ID: 23294032
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Treatment of chronic inflammatory polyradiculoneuropathy].
    Nicolas G
    Rev Med Interne; 2008 Jun; 29 Spec No 2():1-8. PubMed ID: 18927988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical-neurophysiological correlations in chronic inflammatory demyelinating polyradiculoneuropathy patients treated with subcutaneous immunoglobulin.
    Cirillo G; Todisco V; Ricciardi D; Tedeschi G
    Muscle Nerve; 2019 Dec; 60(6):662-667. PubMed ID: 31415091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy.
    Klehmet J; Tackenberg B; Haas J; Kieseier BC
    BMC Neurol; 2023 May; 23(1):207. PubMed ID: 37237267
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Childhood chronic inflammatory demyelinating polyneuroradiculopathy--three cases and a review of the literature.
    Riekhoff AG; Jadoul C; Mercelis R; Cras P; Ceulemans BP
    Eur J Paediatr Neurol; 2012 Jul; 16(4):315-31. PubMed ID: 22225859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg.
    Caro XJ; Winter EF; Dumas AJ
    Rheumatology (Oxford); 2008 Feb; 47(2):208-11. PubMed ID: 18208823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment with interferon-alpha 2a in a patient with chronic inflammatory demyelinating polyneuropathy].
    Ueda M; Ota K; Takeuchi M; Tsutsumi Y; Iwata M
    Rinsho Shinkeigaku; 2000 Feb; 40(2):155-9. PubMed ID: 10835937
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic inflammatory demyelinating polyneuropathy: Plasmapheresis or cyclosporine can be good treatment options in refractory cases.
    Kim W; Shim YK; Choi SA; Kim SY; Kim H; Lim BC; Hwang H; Choi J; Kim KJ; Chae JH
    Neuromuscul Disord; 2019 Sep; 29(9):684-692. PubMed ID: 31473049
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.